Read + Share
Amedeo Smart
Independent Medical Education
Whittle JR, Vaillant F, Surgenor E, Policheni AN, et al. Dual targeting of CDK4/6 and BCL2 pathways augments tumor response in estrogen receptor positive breast cancer. Clin Cancer Res 2020 Apr 3. pii: 1078-0432.CCR-19-1872.PMID: 32245900
Email
LinkedIn
Facebook
Twitter
Privacy Policy